Video

Yutao Liu from Georgia Regents University: Delaying the Progression of Glaucoma

Author(s):

Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.

At the ARVO 2016 meeting in Seattle, WA, Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.

Liu concluded, "One thing I want to emphasize is eye disease is a very severe disease. Especially for glaucoma, the main thing is that in the clinic, most people are not aware of the glaucoma they have because it's a painless disease. So, we recommend people over the age of 40 to go see a clinician in opthalmology to do an eye exam to serve as the baseline, since glaucoma depends on progression."

Related Videos
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
Looking Deeper into Genetic Variants of FSGS, with Jennifer Lai Yee, MD, PhD, MPH
Abdul Abdellatif, MD: More Gout Education Needed for Nephrologists
Violeta Popov, MD, PhD | Credit: ACG
Satish Rao, MD, PhD | Credit: ACG
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
Jonathan Barratt, MD, PhD | Credit: IgA Nephropathy Foundation
© 2024 MJH Life Sciences

All rights reserved.